These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 6611791)

  • 21. Activated astrocytes display increased 5-HT2a receptor expression in pathological states.
    Wu C; Singh SK; Dias P; Kumar S; Mann DM
    Exp Neurol; 1999 Aug; 158(2):529-33. PubMed ID: 10415157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diurnal changes in serotonin content of frontal pole and pain sensitivity in the rat.
    Schlosberg AJ; Harvey JA
    Physiol Behav; 1978 Feb; 20(2):117-20. PubMed ID: 566443
    [No Abstract]   [Full Text] [Related]  

  • 23. Variability of respiratory movements in chronic schizophrenics.
    Tan BK
    Psychiatr Neurol Neurochir; 1970; 73(4):301-8. PubMed ID: 5478774
    [No Abstract]   [Full Text] [Related]  

  • 24. 5-Hydroxytryptamine metabolism in schizophrenics.
    Shen YC; Zhang WH
    Chin Med J (Engl); 1979 Dec; 92(12):817-21. PubMed ID: 117985
    [No Abstract]   [Full Text] [Related]  

  • 25. [Investigations on the behavior of phosphoric acid compounds in the blood of schizophrenics].
    Biesold D; Weise K; Canzler E
    Psychiatr Neurol Med Psychol (Leipz); 1965 Jun; 17(6):232-9. PubMed ID: 5832598
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavior of blood radioactivity after administration of C-14-labeled 5-hydroxytryptamine in normal subjects and schizophrenics].
    De Maio D; Pasquariello G; Bruno A; Faggioli L
    Psychopharmacologia; 1965 Mar; 7(3):230-4. PubMed ID: 5831746
    [No Abstract]   [Full Text] [Related]  

  • 27. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics.
    Mita T; Hanada S; Nishino N; Kuno T; Nakai H; Yamadori T; Mizoi Y; Tanaka C
    Biol Psychiatry; 1986 Dec; 21(14):1407-14. PubMed ID: 2947636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment.
    Hernandez I; Sokolov BP
    J Neurosci Res; 2000 Jan; 59(2):218-25. PubMed ID: 10650880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biochemical analysis of neurotransmitters and receptors in prefrontal cortex of post-mortem brains from schizophrenic patients].
    Toru M; Watanabe S; Nishikawa T; Noda K; Mitsushio H; Mataga N; Takashima M; Shibuya H
    Seishin Shinkeigaku Zasshi; 1982; 84(12):947-61. PubMed ID: 6134296
    [No Abstract]   [Full Text] [Related]  

  • 30. Postmortem serotonergic and adrenergic receptor binding to frontal cortex: correlations with suicide.
    Mann JJ; McBride PA; Stanley M
    Psychopharmacol Bull; 1986; 22(3):647-9. PubMed ID: 3025907
    [No Abstract]   [Full Text] [Related]  

  • 31. [Serotonin].
    Saijoh K
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():527-30. PubMed ID: 8753297
    [No Abstract]   [Full Text] [Related]  

  • 32. [Reduced serotonin receptors in the brain of chronic schizophrenics].
    Mita T
    Seishin Shinkeigaku Zasshi; 1983 Mar; 85(3):190-3. PubMed ID: 6611791
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.